Regulatory Compliance

Stockholm – October 02, 2026 -- Autoliv, Inc. (NYSE: ALV; SSE: ALIVsdb) has appointed Natalie Draisin and Thomas Manfred Müller to its Research Advisory Board, expanding a panel of external experts that guides the automotive safety supplier's long-term research agenda.

Autoliv broadens external expertise with public health and automotive industry veterans

Natalie Draisin serves as Director of the North American Office and United Nations Representative at FIA Foundation and is an External Affiliate at Johns Hopkins Bloomberg School of Public Health. Thomas Manfred Müller, PhD, is a board member, advisor and business angel with executive experience at Audi, BMW, Volvo Cars, and Volkswagen Group.

Seoul – October 02, 2026 -- AUTOCRYPT has established a Public Key Infrastructure (PKI) system for Plug&Charge (PnC) services in South Korea, validated across electric vehicles from six global automotive brands.

Six automakers validate shared authentication framework

The PKI infrastructure was tested on vehicles from Hyundai Motor, Kia, KG Mobility, BMW, Mercedes-Benz and Tesla, enabling these brands to connect to charging point operators (CPOs) through a single authentication system rather than separate proprietary frameworks.

Milan – October 02, 2026 -- Hansoh Pharma's dual-biased GLP-1/GIP receptor agonist Olatorepatide (HS-20094) achieved a mean weight loss of 19.3% at Week 48 in the 15 mg dose group of a Phase III Chinese trial, with no plateau observed in the weight-loss curve.

The data, presented as a Late-breaking Abstract oral presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting running September 28 to October 2, 2026 in Milan, come from the LIGHTEN study, a multicenter, randomized, double-blind, placebo-controlled trial enrolling 604 Chinese adults with overweight or obesity.

Trial enrolled 604 participants across four dose arms over 48 weeks

Participants with a BMI of 28 kg/m2 or above, or 24-28 kg/m2 with a weight-related comorbidity, were randomized 1:1:1:1 to once-weekly subcutaneous Olatorepatide at 5mg, 10mg or 15mg, or placebo. A total of 90.1% completed the full 48-week treatment period.

St. Louis – October 02, 2026 -- DOOR (OTC: LTCH) has finalized a settlement with the U.S. Securities and Exchange Commission, closing a four-year investigation into legacy revenue recognition and key performance indicator practices with a $1.0 million civil penalty payable in quarterly installments.

SEC closes investigation that began in 2022

The SEC approved the previously disclosed settlement, which the Company first announced in principle on October 02, 2026. DOOR consented to an administrative order without admitting or denying the regulator's findings.

Company filed seven years of restated financial statements

Since late 2024, DOOR has filed seven years of financial statements, including restated prior periods, becoming current with its SEC reporting obligations in February 2026 for the first time since mid-2022.

Granite Bay, Calif. – October 02, 2026 -- GMP Labeling Inc. is marking Manufacturing Day 2026 by positioning its nearly 40-year domestic production history as a hedge against global supply chain disruption for pharmaceutical and biotechnology manufacturers. The California-based company, founded in 1987, manufactures quality control labels, sample identification tags, and equipment status markers used across regulated production lines.

Label failures can halt regulated production lines

Material inconsistencies or shipping delays in compliance labeling can interrupt manufacturing workflows, complicate federal audits, and compromise quality records, according to the company. Robin Kalsbeek, General Manager of GMP Labeling, said a label functions as a critical element of traceability and compliance rather than a minor supply item in biotechnology and medical manufacturing settings.

London – October 02, 2026 -- Curaleaf International's Que Medical Inhalation Device (QMID) has become the first cannabis inhalation device to secure registration from Australia's Therapeutic Goods Administration, clearing the way for clinicians to prescribe a standardized-dosing device in a market that has treated more than one million patients since 2016.

TGA Grants Class IIb Status to QMID on October 02, 2026

The device, developed with Jupiter Research LLC, was listed in the Australian Register of Therapeutic Goods as a Class IIb Medical Device, marking the first regulatory approval in Australia for a device delivering Cannabis Sativa L. extracts via patient inhalation. The approval follows a multi-year regulatory process and arrives one year after QMID received EU Medical Device Registration.

Austin, Texas – October 02, 2026 -- SerpApi, a provider of structured search data APIs, has achieved ISO/IEC 27701:2019 certification, an internationally recognized standard for Privacy Information Management Systems (PIMS).

SerpApi adds privacy certification to existing security compliance stack

The ISO/IEC 27701 certification follows SerpApi's completion of a SOC 2 Type 2 examination, issuance of a SOC 3 report, and prior achievement of ISO/IEC 27001:2022 certification. The standard requires organizations to meet strict requirements for managing risks tied to personally identifiable information (PII).

New York – October 02, 2026 -- The American National Standards Institute (ANSI) and America Makes have launched a searchable online database of additive manufacturing (AM) standards alongside a September 2026 Gaps Progress Report, giving manufacturers and regulators a clearer map of which safety and performance standards exist, which are in development, and where coverage is still missing.

Both tools originate from the Additive Manufacturing Standardization Collaborative (AMSC), a cross-sector body jointly led by ANSI and America Makes, as AM adoption expands into aerospace, medical devices, automotive, and defense applications where parts from different machines and manufacturers must perform consistently.

Redwood City, Calif. – October 02, 2026 -- Spacelift, an infrastructure orchestration company, has been named a finalist in SiliconANGLE's 2026 TechForward Awards in the AI-Driven Cloud Infrastructure category.

Spacelift applies policy-as-code controls to AI-assisted infrastructure changes

The company extends the same governance used in traditional infrastructure-as-code pipelines to AI-driven provisioning, including policy-as-code enforcement through Open Policy Agent, role-based access control, approval gates, drift detection, and a complete audit history of system changes and operators. The platform covers Terraform, OpenTofu, Pulumi, CloudFormation, Ansible and Kubernetes.

Metro Chicago – October 02, 2026 -- Calamos Investments has declared monthly distributions paid in October 2026 across seven of its closed-end funds, accompanied by mandatory source-of-distribution disclosures required under Section 19 of the Investment Company Act of 1940.

Seven closed-end funds confirm October payouts under distribution plans

The affected funds trade on Nasdaq under tickers CHI, CHY, CSQ, CGO, CHW, CCD and CPZ. Calamos Global Total Return Fund, Calamos Global Dynamic Income Fund, Calamos Dynamic Convertible and Income Fund, Calamos Convertible Opportunities and Income Fund, and Calamos Convertible and High Income Fund are reporting estimated distribution sources based on year-to-date cumulative experience, with the firm attributing these estimates equally across each regular distribution for the year.